スマートドラッグデリバリーシステムの世界市場レポート 2025年

スマートドラッグデリバリーシステム市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR19.6％で310億1,000万米ドルに成長します。予測期間の成長は、非感染性疾患の負担増、精密医療への注目の高まり、予後診断の台頭、非侵襲的ドラッグデリバリー法の需要増、ヘルスケア支出の増加に起因すると考えられます。予測期間における主な動向としては、小型化・微細加工技術、材料科学の進歩、人工知能（AI）と機械学習（ML）の統合、ナノサイズのドラッグデリバリーシステムの開発、IoTとウェアラブル技術の統合などが挙げられます。

慢性疾患の有病率の増加は、スマートドラッグデリバリーシステム市場の拡大を促進すると予想されます。慢性疾患は、徐々に発症する長期的な健康状態であり、多くの場合、複合的な要因によって引き起こされます。これらの疾患の有病率の増加は、人口の高齢化、環境要因、ヘルスケアアクセスにおける格差の影響を受けています。スマートドラッグデリバリーシステムは、投薬効果を改善し、患者のアドヒアランスを向上させることで、慢性疾患を管理する有望なソリューションを提示しています。例えば、米国の医学図書館である国立医学図書館が2023年1月に発表した報告書によると、2050年までに米国で少なくとも1つの慢性疾患を持つ人は1億4,266万人に達し、2020年の7,152万2,000人から99.5％増加すると予測されています。その結果、慢性疾患の有病率の増加がスマートドラッグデリバリーシステム市場の成長を牽引しています。

スマートドラッグデリバリーシステム市場の主なプレーヤーは、薬剤投与に革命をもたらす革新的な再利用可能ドラッグデリバリー機器の開発に注力しています。そのひとつがQfinityで、薬剤の皮下自己投与用に設計された再利用可能なドラッグデリバリー機器です。Qfinityは単回使用とは異なり、複数回の注射に利用できるため、廃棄物を減らし、環境面でもメリットがあります。例えば、Jabil Inc.は2022年5月にQfinityを発売しました。この装置は1台当たり100回以上の注射が可能で、様々なプレフィルドカートリッジに対応しています。この装置は、注射1本あたりの二酸化炭素排出量を削減するだけでなく、さまざまな薬剤量や粘度に対応する汎用性も備えています。さらに、コネクテッド・バージョンのQfinity+は、内蔵センサーと電子機器により、患者ケアとコンプライアンスの遠隔監視を可能にし、使いやすさを損なうことなく接続性を確保しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のスマートドラッグデリバリーシステムPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のスマートドラッグデリバリーシステム市場：成長率分析
• 世界のスマートドラッグデリバリーシステム市場の実績：規模と成長、2019年～2024年
• 世界のスマートドラッグデリバリーシステム市場の予測：規模と成長、2024年～2029年、2034年
• 世界のスマートドラッグデリバリーシステム総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のスマートドラッグデリバリーシステム市場：製品別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 接続型吸入器
• 接続型オートインジェクター
• 接続型ペン型注射器
• 接続型ウェアラブルインジェクター
• アドオンセンサー
• その他の製品
• 世界のスマートドラッグデリバリーシステム市場：治療領域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 代謝障害
• 神経疾患
• 呼吸器疾患
• ホルモン障害
• その他の治療領域
• 世界のスマートドラッグデリバリーシステム市場：ドラッグデリバリーモード別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 注射可能
• 吸入
• 経口
• 世界のスマートドラッグデリバリーシステム市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• クリニック
• ホームケア
• 外来診療環境
• その他のエンドユーザー
• 世界のスマートドラッグデリバリーシステム市場、接続型吸入器のタイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• ドライパウダー吸入器（DPI）
• 定量噴霧式吸入器（MDI）
• 世界のスマートドラッグデリバリーシステム市場、接続型オートインジェクターのサブセグメンテーション（タイプ別）、実績と予測、2019年～2024年、2024年～2029年、2034年
• 単回投与オートインジェクター
• マルチドーズオートインジェクター
• 世界のスマートドラッグデリバリーシステム市場、接続型ペン型注射器タイプ別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• インスリンペン型注射器
• 生物学的製剤ペン型注射器
• 世界のスマートドラッグデリバリーシステム市場、接続型ウェアラブルインジェクターのタイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• インスリンウェアラブル注射器
• 輸液ポンプウェアラブルインジェクター
• 世界のスマートドラッグデリバリーシステム市場、アドオンセンサーのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 血糖値モニタリングセンサー
• 服薬遵守センサー
• 温度センサー
• 世界のスマートドラッグデリバリーシステム市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• スマートシリンジ
• スマートパッチ
• スマートインプラント

第7章 地域別・国別分析

• 世界のスマートドラッグデリバリーシステム市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のスマートドラッグデリバリーシステム市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• スマートドラッグデリバリーシステム市場：競合情勢
• スマートドラッグデリバリーシステム市場：企業プロファイル
  • Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic plc
• Eli Lilly and Company
• Amgen Inc
• Novo Nordisk
• Merck Group
• Becton Dickinson and Company
• Stryker Corporation
• Baxter International Inc
• Boston Scientific Corporation
• Biogen Inc
• Vertex Pharmaceuticals Incorporated
• Phillips-Medisize Corporation
• ResMed Inc
• West Pharmaceutical Services Inc
• Insulet Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• スマートドラッグデリバリーシステム市場2029年：新たな機会を提供する国
• スマートドラッグデリバリーシステム市場2029年：新たな機会を提供するセグメント
• スマートドラッグデリバリーシステム市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Smart drug delivery systems encompass advanced technologies aimed at enhancing the efficacy, safety, and targeted delivery of pharmaceutical compounds within the body. These systems utilize diverse approaches to regulate drug release, improve bioavailability, and minimize adverse effects.

The primary products within smart drug delivery systems include connected inhalers, connected autoinjectors, connected pen injectors, connected wearable injectors, add-on sensors, and other related devices. Connected inhalers, for instance, are electronic monitoring systems integrated into inhalers, which track drug usage and may provide feedback on device technique. These systems find applications across various therapeutic areas such as metabolic disorders, neurological disorders, respiratory disorders, hormonal disorders, and more. They can deliver drugs via different modes including injectable, inhalation, and oral routes, and cater to a range of end users including hospitals, clinics, home care settings, ambulatory care facilities, among others.

The smart drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides smart drug delivery systems market statistics, including smart drug delivery systems industry global market size, regional shares, competitors with smart drug delivery systems market share, detailed smart drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the smart drug delivery systems industry. This smart drug delivery systems market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $12.65 billion in 2024 to $15.17 billion in 2025 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to increasing demand for drug delivery systems, rising patient compliance, rising prevalence of chronic diseases, increasing personalized medicine, and need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $31.01 billion in 2029 at a compound annual growth rate (CAGR) of 19.6%. The growth in the forecast period can be attributed to growing burden of non-communicable diseases, increased focus on precision medicine, the rise of theragnostic, growing demand for non-invasive drug delivery methods, and increasing healthcare expenditure. Major trends in the forecast period include miniaturization and microfabrication technologies, advancements in material science, integration of artificial intelligence (AI) and machine learning (ML), development of nano-sized drug delivery systems, and integration of IoT and wearable technology.

The growing prevalence of chronic diseases is expected to drive the expansion of the smart drug delivery systems market. Chronic diseases are long-term health conditions that develop gradually and are often caused by a combination of factors. The increasing prevalence of these diseases is influenced by aging populations, environmental factors, and disparities in healthcare access. Smart drug delivery systems present a promising solution for managing chronic diseases by improving medication effectiveness and enhancing patient adherence. For example, a January 2023 report from the National Library of Medicine, a US-based medical library, projects that by 2050, 142.66 million people in the United States will have at least one chronic illness, representing a 99.5% increase from 71.522 million in 2020. As a result, the rising prevalence of chronic diseases is driving growth in the smart drug delivery systems market.

Key players in the smart drug delivery systems market are focused on developing innovative reusable drug delivery devices to revolutionize drug administration. One such device is Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of medication. Unlike single-use devices, Qfinity can be utilized for multiple injections, reducing waste and offering environmental benefits. For instance, Jabil Inc. launched Qfinity in May 2022, featuring the capability to handle over 100 injections per device and accommodating various pre-filled cartridges. The device not only reduces the carbon footprint per injection but also offers versatility in handling different drug volumes and viscosities. Additionally, the connected version, Qfinity+, enables remote monitoring of patient care and compliance through built-in sensors and electronics, ensuring connectivity without compromising ease of use.

In October 2023, Novo Nordisk A/S strengthened its position in the smart drug delivery systems market through the acquisition of Biocorp Production SA for $164.5 million. This strategic move aims to augment Novo Nordisk's capabilities in developing innovative connected devices and delivery solutions, exemplified by Mallya, a smart add-on device for pen injectors. Biocorp, a France-based designer and manufacturer of medical devices and drug delivery systems, brings expertise in connected devices that align with Novo Nordisk's focus on advancing drug delivery technologies to enhance patient care and treatment outcomes.

Major companies operating in the smart drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biogen Inc., Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc., Insulet Corporation, Owen Mumford Ltd., Sonceboz, H&T Presspart Manufacturing Ltd., E3D Elcam Drug Delivery Devices, CeQur Corporation

North America was the largest region in the smart drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart drug delivery systems market consists of revenues earned by entities by providing services such as personalized drug delivery, targeted treatment, diagnostic integration, remote monitoring, and feedback mechanisms. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart drug delivery systems market also includes sales of products including microfluidic devices, transdermal drug delivery patches, electroceutical devices, and remote-controlled drug delivery devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Connected Inhalers; Connected Autoinjectors; Connected Pen Injectors; Connected Wearable Injectors; Add-On Sensors; Other Products
• 2) By Therapeutic Area: Metabolic Disorders; Neurological Disorders; Respiratory Disorders; Hormonal Disorders; Other Therapeutic Areas
• 3) By Drug Delivery Mode: Injectable; Inhalation; Oral
• 4) By End-User: Hospitals; Clinics; Home Care; Ambulatory Care Settings; Other End-Users
• Subsegments:
• 1) By Connected Inhalers: Dry Powder Inhalers (DPIs); Metered Dose Inhalers (MDIs)
• 2) By Connected Autoinjectors: Single-Dose Autoinjectors; Multi-Dose Autoinjectors
• 3) By Connected Pen Injectors: Insulin Pen Injectors; Biologic Pen Injectors
• 4) By Connected Wearable Injectors: Insulin Wearable Injectors; Infusion Pump Wearable Injectors
• 5) By Add-On Sensors: Glucose Monitoring Sensors; Medication Adherence Sensors; Temperature Sensors
• 6) By Other Products: Smart Syringes; Smart Patches; Smart Implants
• Companies Mentioned: Pfizer Inc; Johnson & Johnson; Bayer AG; Abbott Laboratories; Novartis International AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Drug Delivery Systems Market Characteristics

3. Smart Drug Delivery Systems Market Trends And Strategies

4. Smart Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Smart Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Smart Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Smart Drug Delivery Systems Market Growth Rate Analysis
• 5.4. Global Smart Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Smart Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Smart Drug Delivery Systems Total Addressable Market (TAM)

6. Smart Drug Delivery Systems Market Segmentation

• 6.1. Global Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Connected Inhalers
• Connected Autoinjectors
• Connected Pen Injectors
• Connected Wearable Injectors
• Add-On Sensors
• Other Products
• 6.2. Global Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metabolic Disorders
• Neurological Disorders
• Respiratory Disorders
• Hormonal Disorders
• Other Therapeutic Areas
• 6.3. Global Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Inhalation
• Oral
• 6.4. Global Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Care
• Ambulatory Care Settings
• Other End-Users
• 6.5. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dry Powder Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)
• 6.6. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Autoinjectors
• Multi-Dose Autoinjectors
• 6.7. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Pen Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin Pen Injectors
• Biologic Pen Injectors
• 6.8. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Wearable Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin Wearable Injectors
• Infusion Pump Wearable Injectors
• 6.9. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Add-On Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucose Monitoring Sensors
• Medication Adherence Sensors
• Temperature Sensors
• 6.10. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Smart Syringes
• Smart Patches
• Smart Implants

7. Smart Drug Delivery Systems Market Regional And Country Analysis

• 7.1. Global Smart Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Smart Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Drug Delivery Systems Market

• 8.1. Asia-Pacific Smart Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Drug Delivery Systems Market

• 9.1. China Smart Drug Delivery Systems Market Overview
• 9.2. China Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Drug Delivery Systems Market

• 10.1. India Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Drug Delivery Systems Market

• 11.1. Japan Smart Drug Delivery Systems Market Overview
• 11.2. Japan Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Drug Delivery Systems Market

• 12.1. Australia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Drug Delivery Systems Market

• 13.1. Indonesia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Drug Delivery Systems Market

• 14.1. South Korea Smart Drug Delivery Systems Market Overview
• 14.2. South Korea Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Drug Delivery Systems Market

• 15.1. Western Europe Smart Drug Delivery Systems Market Overview
• 15.2. Western Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Drug Delivery Systems Market

• 16.1. UK Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Drug Delivery Systems Market

• 17.1. Germany Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Drug Delivery Systems Market

• 18.1. France Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Drug Delivery Systems Market

• 19.1. Italy Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Drug Delivery Systems Market

• 20.1. Spain Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Drug Delivery Systems Market

• 21.1. Eastern Europe Smart Drug Delivery Systems Market Overview
• 21.2. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Drug Delivery Systems Market

• 22.1. Russia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Drug Delivery Systems Market

• 23.1. North America Smart Drug Delivery Systems Market Overview
• 23.2. North America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Drug Delivery Systems Market

• 24.1. USA Smart Drug Delivery Systems Market Overview
• 24.2. USA Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Drug Delivery Systems Market

• 25.1. Canada Smart Drug Delivery Systems Market Overview
• 25.2. Canada Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Drug Delivery Systems Market

• 26.1. South America Smart Drug Delivery Systems Market Overview
• 26.2. South America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Drug Delivery Systems Market

• 27.1. Brazil Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Drug Delivery Systems Market

• 28.1. Middle East Smart Drug Delivery Systems Market Overview
• 28.2. Middle East Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Drug Delivery Systems Market

• 29.1. Africa Smart Drug Delivery Systems Market Overview
• 29.2. Africa Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 30.1. Smart Drug Delivery Systems Market Competitive Landscape
• 30.2. Smart Drug Delivery Systems Market Company Profiles
  • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Smart Drug Delivery Systems Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Eli Lilly and Company
• 31.3. Amgen Inc
• 31.4. Novo Nordisk
• 31.5. Merck Group
• 31.6. Becton Dickinson and Company
• 31.7. Stryker Corporation
• 31.8. Baxter International Inc
• 31.9. Boston Scientific Corporation
• 31.10. Biogen Inc
• 31.11. Vertex Pharmaceuticals Incorporated
• 31.12. Phillips-Medisize Corporation
• 31.13. ResMed Inc
• 31.14. West Pharmaceutical Services Inc
• 31.15. Insulet Corporation

32. Global Smart Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Drug Delivery Systems Market

34. Recent Developments In The Smart Drug Delivery Systems Market

35. Smart Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 35.1 Smart Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Smart Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Smart Drug Delivery Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer